Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Women with PCOS have altered brain structure and reduced cognitive performance.

Menopause reduces skin fat, but treatments like magnolol and PLLA-SCA can help restore skin health.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

More body hair in young Australian women is linked to higher androstenedione levels.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Women with PCOS from minority backgrounds have worse mental health and quality of life.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Women with cicatricial hair loss may have a higher risk of hypertension.

Flaxseed lignans may reduce breast cancer risk in women.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Homeopathy improved hair loss and well-being in a woman with chronic hair loss.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Most women felt positive after stopping oral contraceptive pills despite some side effects.

Temporal hair loss relates to overall scalp hair loss in women.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Women with PCOS often have severe PMS, but managing anemia and regular menstruation can help reduce symptoms.

Ayurvedic treatment improved PCOS symptoms in a 40-year-old woman.